(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PRKAA2 mRNA] CTD PMID:31150632 (+)-taxifolin decreases phosphorylation ISO PRKAA2 (Homo sapiens) 6480464 taxifolin results in decreased phosphorylation of PRKAA2 protein CTD PMID:23691032 (-)-Arctigenin increases phosphorylation ISO PRKAA2 (Homo sapiens) 6480464 arctigenin results in increased phosphorylation of PRKAA2 protein CTD PMID:23691032 (-)-matairesinol increases phosphorylation ISO PRKAA2 (Homo sapiens) 6480464 matairesinol results in increased phosphorylation of PRKAA2 protein CTD PMID:23691032 (R)-lipoic acid multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [Thioctic Acid co-treated with Silicon] results in increased expression of PRKAA2 mRNA CTD PMID:34252510 (R,R)-tramadol multiple interactions EXP 6480464 [Tiletamine co-treated with Xylazine co-treated with Tramadol] results in increased expression of PRKAA2 mRNA CTD PMID:31276069 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of PRKAA2 mRNA CTD PMID:22265867 1,1-dichloroethene decreases expression ISO Prkaa2 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of PRKAA2 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO Prkaa2 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of PRKAA2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO Prkaa2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of PRKAA2 mRNA CTD PMID:22206623 1,3,7,9-tetramethyluric acid multiple interactions EXP 6480464 1 more ... CTD PMID:35872049 17alpha-ethynylestradiol multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRKAA2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PRKAA2 mRNA CTD PMID:29097150 17beta-estradiol multiple interactions ISO Prkaa2 (Mus musculus) 6480464 Estradiol inhibits the reaction [Dihydrotestosterone results in decreased phosphorylation of PRKAA2 protein] CTD PMID:16990341 17beta-estradiol multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of PRKAA2 mRNA CTD PMID:30165855 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of PRKAA2 mRNA CTD PMID:26496021 17beta-estradiol decreases expression ISO Prkaa2 (Mus musculus) 6480464 Estradiol results in decreased expression of PRKAA2 mRNA CTD PMID:19484750 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PRKAA2 mRNA CTD PMID:20068009 and PMID:32145629 17beta-hydroxy-5alpha-androstan-3-one decreases phosphorylation ISO Prkaa2 (Mus musculus) 6480464 Dihydrotestosterone results in decreased phosphorylation of PRKAA2 protein CTD PMID:16990341 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO Prkaa2 (Mus musculus) 6480464 Estradiol inhibits the reaction [Dihydrotestosterone results in decreased phosphorylation of PRKAA2 protein] CTD PMID:16990341 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRKAA2 mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PRKAA2 gene] CTD PMID:17942748 and PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Prkaa2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of PRKAA2 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Prkaa2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of PRKAA2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRKAA2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PRKAA2 mRNA CTD PMID:22298810 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:29474705 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of PRKAA2 mRNA CTD PMID:30723492 4-hydroxy-3-[4-(2-hydroxyphenyl)phenyl]-6-oxo-7H-thieno[2,3-b]pyridine-5-carbonitrile multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [[PRKAA1 gene co-treated with PRKAA2 gene] affects the susceptibility to 4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2 more ... CTD PMID:31974165 4-hydroxy-TEMPO multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 tempol inhibits the reaction [PRKAA2 protein affects the expression of HSPA5 protein] CTD PMID:21145922 4-nonylphenol multiple interactions EXP 6480464 [4-nonylphenol results in increased susceptibility to bisphenol A] which results in decreased expression of PRKAA2 mRNA and [bisphenol A co-treated with 4-nonylphenol] results in decreased expression of PRKAA2 mRNA CTD PMID:30228064 acadesine multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 acadesine promotes the reaction [Capsaicin results in increased expression of PRKAA2 protein] CTD PMID:36044967 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of PRKAA2 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of PRKAA2 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO Prkaa2 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of PRKAA2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO PRKAA2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of PRKAA2 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO PRKAA2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of PRKAA2 mRNA CTD PMID:22100608 aflatoxin M1 decreases expression ISO PRKAA2 (Homo sapiens) 6480464 Aflatoxin M1 results in decreased expression of PRKAA2 mRNA CTD PMID:30928695 AICA ribonucleotide multiple interactions ISO Prkaa2 (Mus musculus) 6480464 PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]] more ... CTD PMID:15806154 and PMID:21454484 AICA ribonucleotide multiple interactions EXP 6480464 PRKAA2 protein promotes the reaction [AICA ribonucleotide promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA]] CTD PMID:22815988 AICA ribonucleotide increases phosphorylation ISO PRKAA2 (Homo sapiens) 6480464 AICA ribonucleotide results in increased phosphorylation of PRKAA2 protein CTD PMID:18482975 AICA ribonucleotide multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 AICA ribonucleotide results in increased phosphorylation of and results in increased activity of PRKAA2 protein and PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CYP4F2 mRNA] CTD PMID:16873680 and PMID:21205922 albuterol increases expression ISO Prkaa2 (Mus musculus) 6480464 Albuterol results in increased expression of PRKAA2 mRNA CTD PMID:36822333 aldehydo-D-glucose multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides more ... CTD PMID:18482975 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of PRKAA2 mRNA and Glucose results in decreased expression of PRKAA2 protein CTD PMID:24349266 aldehydo-D-glucose affects response to substance EXP 6480464 PRKAA2 protein mutant form affects the susceptibility to Glucose deficiency CTD PMID:15806154 aldehydo-D-glucose multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]] which results in decreased abundance of Adenosine Triphosphate more ... CTD PMID:15806154 more ... amiodarone increases phosphorylation ISO PRKAA2 (Homo sapiens) 6480464 Amiodarone results in increased phosphorylation of PRKAA2 protein CTD PMID:23912912 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PRKAA2 mRNA CTD PMID:16483693 amosite asbestos decreases methylation ISO PRKAA2 (Homo sapiens) 6480464 Asbestos and Amosite results in decreased methylation of PRKAA2 promoter CTD PMID:29626692 Arctiin increases phosphorylation ISO PRKAA2 (Homo sapiens) 6480464 arctiin results in increased phosphorylation of PRKAA2 protein CTD PMID:23691032 aristolochic acid A decreases expression ISO PRKAA2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of PRKAA2 mRNA CTD PMID:33212167 ATP multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [[PRKAA1 gene co-treated with PRKAA2 gene] affects the susceptibility to Metformin] which results in decreased abundance of Adenosine Triphosphate more ... CTD PMID:31974165 atrazine multiple interactions ISO Prkaa2 (Mus musculus) 6480464 Lycopene inhibits the reaction [Atrazine results in increased expression of PRKAA2 mRNA] and Lycopene inhibits the reaction [Atrazine results in increased phosphorylation of PRKAA2 protein] CTD PMID:30360616 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of PRKAA2 mRNA CTD PMID:36841081 atrazine increases expression ISO Prkaa2 (Mus musculus) 6480464 Atrazine results in increased expression of PRKAA2 mRNA CTD PMID:30360616 atrazine increases phosphorylation ISO Prkaa2 (Mus musculus) 6480464 Atrazine results in increased phosphorylation of PRKAA2 protein CTD PMID:30360616 bafilomycin A1 multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 bafilomycin A1 inhibits the reaction [2-chloroethyl ethyl sulfide results in decreased expression of PRKAA2 protein] CTD PMID:37481222 benzalkonium chloride increases expression ISO Prkaa2 (Mus musculus) 6480464 Benzalkonium Compounds results in increased expression of PRKAA2 mRNA CTD PMID:31199489 benzo[a]pyrene decreases expression ISO Prkaa2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of PRKAA2 mRNA CTD PMID:22228805 benzo[a]pyrene decreases methylation ISO PRKAA2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of PRKAA2 3' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO PRKAA2 (Homo sapiens) 6480464 7 more ... CTD PMID:20018196 bisphenol A decreases phosphorylation ISO Prkaa2 (Mus musculus) 6480464 bisphenol A results in decreased phosphorylation of PRKAA2 protein CTD PMID:36858637 bisphenol A increases phosphorylation ISO PRKAA2 (Homo sapiens) 6480464 bisphenol A results in increased phosphorylation of PRKAA2 protein CTD PMID:36232920 bisphenol A multiple interactions ISO Prkaa2 (Mus musculus) 6480464 VDAC1 promotes the reaction [bisphenol A results in decreased phosphorylation of PRKAA2 protein] CTD PMID:36858637 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PRKAA2 mRNA CTD PMID:32145629 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PRKAA2 mRNA CTD PMID:27539358 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PRKAA2 gene CTD PMID:28505145 bisphenol A increases methylation ISO Prkaa2 (Mus musculus) 6480464 bisphenol A results in increased methylation of PRKAA2 promoter CTD PMID:27312807 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PRKAA2 mRNA CTD PMID:25181051 more ... bisphenol A multiple interactions EXP 6480464 [4-nonylphenol results in increased susceptibility to bisphenol A] which results in decreased expression of PRKAA2 mRNA more ... CTD PMID:26496021 and PMID:30228064 bortezomib multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 Bortezomib inhibits the reaction [geldanamycin results in decreased expression of and results in decreased phosphorylation of PRKAA2 protein] CTD PMID:37481222 butanal decreases expression ISO PRKAA2 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of PRKAA2 mRNA CTD PMID:26079696 cadmium sulfate multiple interactions ISO Prkaa2 (Mus musculus) 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of PRKAA2 mRNA] CTD PMID:16221973 caffeine increases expression EXP 6480464 Caffeine results in increased expression of PRKAA2 mRNA CTD PMID:22583948 caffeine increases phosphorylation ISO PRKAA2 (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of PRKAA2 protein CTD PMID:35688186 capsaicin increases phosphorylation ISO PRKAA2 (Homo sapiens) 6480464 Capsaicin results in increased phosphorylation of PRKAA2 protein CTD PMID:36044967 capsaicin multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 acadesine promotes the reaction [Capsaicin results in increased expression of PRKAA2 protein] and dorsomorphin inhibits the reaction [Capsaicin results in increased expression of PRKAA2 protein] CTD PMID:36044967 carbon nanotube decreases expression ISO Prkaa2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 carmustine affects response to substance ISO PRKAA2 (Homo sapiens) 6480464 PRKAA2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 carnitine multiple interactions EXP 329955369 L-carnitine inhibits the reaction [sunitinib decreases expression of Ampka2 protein in rat serum and heart] RGD carnitine increases expression EXP 329955369 L-carnitine increases expression of Ampka2 protein in rat serum and heart RGD cisplatin multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PRKAA2 mRNA CTD PMID:27392435 cisplatin decreases expression ISO PRKAA2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of PRKAA2 mRNA CTD PMID:27392435 copper atom decreases expression EXP 6480464 Copper results in decreased expression of PRKAA2 mRNA CTD PMID:22465980 copper atom multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of PRKAA2 mRNA CTD PMID:30911355 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of PRKAA2 mRNA CTD PMID:22465980 copper(0) multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of PRKAA2 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO PRKAA2 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of PRKAA2 mRNA CTD PMID:19549813 cordycepin multiple interactions EXP 6480464 cordycepin inhibits the reaction [testosterone enanthate results in decreased phosphorylation of PRKAA2 protein] CTD PMID:36015278 corosolic acid multiple interactions EXP 6480464 PRKAA2 protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]] more ... CTD PMID:34296331 corosolic acid decreases response to substance ISO Prkaa2 (Mus musculus) 6480464 PRKAA2 gene mutant form results in decreased susceptibility to corosolic acid CTD PMID:34296331 crocidolite asbestos decreases methylation ISO PRKAA2 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased methylation of PRKAA2 promoter CTD PMID:29626692 cyclosporin A decreases expression ISO PRKAA2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of PRKAA2 mRNA CTD PMID:27989131 cyfluthrin decreases expression EXP 6480464 cyfluthrin results in decreased expression of PRKAA2 mRNA CTD PMID:36515635 cyproconazole increases expression ISO Prkaa2 (Mus musculus) 6480464 cyproconazole results in increased expression of PRKAA2 mRNA CTD PMID:22045034 D-glucopyranose 6-phosphate multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [[PRKAA1 gene co-treated with PRKAA2 gene] affects the susceptibility to 4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2 more ... CTD PMID:31974165 D-glucose multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]] which results in decreased abundance of Adenosine Triphosphate more ... CTD PMID:15806154 more ... D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of PRKAA2 mRNA and Glucose results in decreased expression of PRKAA2 protein CTD PMID:24349266 D-glucose multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides more ... CTD PMID:18482975 D-glucose affects response to substance EXP 6480464 PRKAA2 protein mutant form affects the susceptibility to Glucose deficiency CTD PMID:15806154 DDT decreases expression EXP 6480464 DDT results in decreased expression of PRKAA2 mRNA CTD PMID:30207508 Deoxyschizandrin decreases phosphorylation ISO PRKAA2 (Homo sapiens) 6480464 schizandrin A results in decreased phosphorylation of PRKAA2 protein CTD PMID:23691032 dibutyl phthalate increases expression ISO Prkaa2 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of PRKAA2 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO PRKAA2 (Homo sapiens) 6480464 Dibutyl Phthalate results in increased expression of PRKAA2 protein CTD PMID:37356649 dibutyl phthalate multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 Telmisartan inhibits the reaction [Dibutyl Phthalate results in increased expression of PRKAA2 protein] CTD PMID:37356649 dihydroxyacetone multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Dihydroxyacetone co-treated with S 4048]] which results in decreased abundance of Adenosine Triphosphate and [PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Dihydroxyacetone co-treated with S 4048] CTD PMID:31974165 dioxygen increases expression ISO PRKAA2 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of PRKAA2 mRNA CTD PMID:24236059 dioxygen multiple interactions EXP 6480464 Oxygen deficiency results in decreased expression of [PRKAA1 protein binds to PRKAA2 protein] more ... CTD PMID:22892143 and PMID:28983604 dioxygen increases expression EXP 6480464 Oxygen results in increased expression of PRKAA2 mRNA CTD PMID:22911455 dorsomorphin multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:19625624 more ... dorsomorphin multiple interactions ISO Prkaa2 (Mus musculus) 6480464 dorsomorphin inhibits the reaction [pseudolaric acid B results in increased phosphorylation of PRKAA2 protein] CTD PMID:37244295 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of PRKAA2 mRNA CTD PMID:26721193 doxorubicin increases expression ISO PRKAA2 (Homo sapiens) 6480464 Doxorubicin results in increased expression of PRKAA2 mRNA CTD PMID:37062353 doxorubicin multiple interactions EXP 6480464 PRKAA2 protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]] more ... CTD PMID:34296331 doxorubicin decreases expression ISO PRKAA2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of PRKAA2 mRNA CTD PMID:29803840 econazole multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [tebuconazole co-treated with Econazole] results in increased phosphorylation of PRKAA2 protein CTD PMID:30698772 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of PRKAA2 mRNA CTD PMID:29391264 entinostat increases expression ISO PRKAA2 (Homo sapiens) 6480464 entinostat results in increased expression of PRKAA2 mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO Prkaa2 (Mus musculus) 6480464 epoxiconazole results in decreased expression of PRKAA2 mRNA CTD PMID:35436446 ethanol multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [Ethanol co-treated with PRKAA2 protein] affects the expression of PRKAA1 protein more ... CTD PMID:23448468 ethanol multiple interactions EXP 6480464 1 more ... CTD PMID:35872049 fenthion increases expression ISO Prkaa2 (Mus musculus) 6480464 Fenthion results in increased expression of PRKAA2 mRNA CTD PMID:34813904 finasteride multiple interactions EXP 6480464 Finasteride inhibits the reaction [testosterone enanthate results in decreased phosphorylation of PRKAA2 protein] CTD PMID:36015278 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of PRKAA2 mRNA CTD PMID:24136188 folic acid decreases expression ISO Prkaa2 (Mus musculus) 6480464 Folic Acid results in decreased expression of PRKAA2 mRNA CTD PMID:25629700 folpet increases expression ISO Prkaa2 (Mus musculus) 6480464 folpet results in increased expression of PRKAA2 mRNA CTD PMID:31558096 formononetin multiple interactions ISO Prkaa2 (Mus musculus) 6480464 Lipopolysaccharides promotes the reaction [formononetin results in increased phosphorylation of PRKAA2 protein] CTD PMID:37269934 formononetin increases phosphorylation ISO Prkaa2 (Mus musculus) 6480464 formononetin results in increased phosphorylation of PRKAA2 protein CTD PMID:37269934 formoterol fumarate increases expression ISO Prkaa2 (Mus musculus) 6480464 Formoterol Fumarate results in increased expression of PRKAA2 mRNA CTD PMID:36822333 geldanamycin multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 Bortezomib inhibits the reaction [geldanamycin results in decreased expression of and results in decreased phosphorylation of PRKAA2 protein] and geldanamycin results in decreased expression of and results in decreased phosphorylation of PRKAA2 protein CTD PMID:37481222 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PRKAA2 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of PRKAA2 mRNA CTD PMID:24136188 glucose multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [[PRKAA1 gene mutant form co-treated with PRKAA2 gene mutant form] affects the susceptibility to [Glucose co-treated with S 4048]] which results in decreased abundance of Adenosine Triphosphate more ... CTD PMID:15806154 more ... glucose decreases expression EXP 6480464 Glucose results in decreased expression of PRKAA2 mRNA and Glucose results in decreased expression of PRKAA2 protein CTD PMID:24349266 glucose multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides more ... CTD PMID:18482975 glucose affects response to substance EXP 6480464 PRKAA2 protein mutant form affects the susceptibility to Glucose deficiency CTD PMID:15806154 glyphosate decreases expression ISO PRKAA2 (Homo sapiens) 6480464 Glyphosate results in decreased expression of PRKAA2 mRNA CTD PMID:31295307 gramine increases phosphorylation ISO PRKAA2 (Homo sapiens) 6480464 gramine results in increased phosphorylation of PRKAA2 protein CTD PMID:23691032 hexaconazole increases expression ISO Prkaa2 (Mus musculus) 6480464 hexaconazole results in increased expression of PRKAA2 mRNA CTD PMID:22045034 hexadecanoic acid multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of PRKAA2 mRNA CTD PMID:30547786 histamine multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [PRKAA1 protein co-treated with PRKAA2 protein] affects the reaction [Histamine results in increased phosphorylation of NOS2 protein] CTD PMID:21145922 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of PRKAA2 mRNA CTD PMID:36414029 isoprenaline multiple interactions EXP 6480464 xanthone inhibits the reaction [Isoproterenol results in decreased expression of PRKAA2 mRNA] CTD PMID:36414029 lipoic acid multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [Thioctic Acid co-treated with Silicon] results in increased expression of PRKAA2 mRNA CTD PMID:34252510 lipopolysaccharide decreases expression ISO Prkaa2 (Mus musculus) 39456138 lipopolysaccharide decreases expression of Prkaa2 mRNA in left cardiac chamber RGD lipopolysaccharide multiple interactions ISO Prkaa2 (Mus musculus) 6480464 Lipopolysaccharides promotes the reaction [formononetin results in increased phosphorylation of PRKAA2 protein] CTD PMID:37269934 lycopene increases phosphorylation ISO Prkaa2 (Mus musculus) 6480464 Lycopene results in increased phosphorylation of PRKAA2 protein CTD PMID:30360616 lycopene increases expression ISO Prkaa2 (Mus musculus) 6480464 Lycopene results in increased expression of PRKAA2 mRNA CTD PMID:30360616 lycopene multiple interactions ISO Prkaa2 (Mus musculus) 6480464 Lycopene inhibits the reaction [Atrazine results in increased expression of PRKAA2 mRNA] and Lycopene inhibits the reaction [Atrazine results in increased phosphorylation of PRKAA2 protein] CTD PMID:30360616 mercury dichloride decreases expression ISO Prkaa2 (Mus musculus) 6480464 Mercuric Chloride results in decreased expression of PRKAA2 mRNA CTD PMID:22019852 Mesaconitine increases expression EXP 6480464 mesaconitine results in increased expression of PRKAA2 protein CTD PMID:37182599 metformin multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 Metformin inhibits the reaction [2-chloroethyl ethyl sulfide results in decreased phosphorylation of PRKAA2 protein] and Metformin results in increased phosphorylation of and results in increased activity of PRKAA2 protein CTD PMID:16873680 and PMID:37481222 metformin multiple interactions ISO Prkaa2 (Mus musculus) 39456138 metformin inhibits the reaction [lipopolysaccharide decreases expression of Prkaa2 mRNA in left cardiac chamber] and decreases expression of Prkaa2 mRNA in left cardiac chamber RGD metformin increases phosphorylation EXP 6480464 Metformin results in increased phosphorylation of PRKAA2 protein CTD PMID:19594306 metformin increases activity EXP 6480464 Metformin results in increased activity of PRKAA2 protein CTD PMID:18484962 metformin affects response to substance ISO Prkaa2 (Mus musculus) 6480464 PRKAA2 protein affects the susceptibility to Metformin CTD PMID:20847317 metformin multiple interactions EXP 6480464 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Metformin results in increased phosphorylation of and results in increased activity of PRKAA2 protein] and Metformin results in increased phosphorylation of and results in increased activity of PRKAA2 protein CTD PMID:21186350 metformin multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [[PRKAA1 gene co-treated with PRKAA2 gene] affects the susceptibility to Metformin] which results in decreased abundance of Adenosine Triphosphate more ... CTD PMID:19052259 more ... methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of PRKAA2 mRNA CTD PMID:30467583 methidathion increases expression ISO Prkaa2 (Mus musculus) 6480464 methidathion results in increased expression of PRKAA2 mRNA CTD PMID:34813904 methotrexate multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 PRKAA2 mutant form inhibits the reaction [Methotrexate results in increased expression of HMOX1 mRNA] more ... CTD PMID:25575725 N-acetyl-L-cysteine multiple interactions ISO Prkaa2 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [[PRKAA2 protein affects the susceptibility to [Air Pollutants results in increased abundance of Particulate Matter]] which results in increased phosphorylation of RELA protein] more ... CTD PMID:29753072 N-methyl-4-phenylpyridinium affects phosphorylation ISO PRKAA2 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium affects the phosphorylation of PRKAA2 protein CTD PMID:36078115 N-methyl-4-phenylpyridinium multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [1-Methyl-4-phenylpyridinium co-treated with EVA1A protein] results in decreased phosphorylation of PRKAA2 protein CTD PMID:36078115 nickel atom decreases expression ISO PRKAA2 (Homo sapiens) 6480464 Nickel results in decreased expression of PRKAA2 mRNA CTD PMID:24768652 and PMID:25583101 nicotinamide multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 Niacinamide inhibits the reaction [6 more ... CTD PMID:18482975 nicotine increases expression EXP 6480464 Nicotine results in increased expression of PRKAA2 mRNA CTD PMID:22265867 nicotinic acid increases activity ISO PRKAA2 (Homo sapiens) 6480464 Niacin results in increased activity of PRKAA2 protein CTD PMID:14749208 nitrites multiple interactions EXP 6480464 PRKAA2 mutant form inhibits the reaction [[Nitrites co-treated with Oxygen deficiency] results in increased expression of PPARGC1A mRNA] CTD PMID:22892143 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of PRKAA2 mRNA CTD PMID:26720608 nordihydroguaiaretic acid increases phosphorylation EXP 329955565 NDGA increases phosphorylation in liver of high fructose fed rats RGD oleic acid multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of PRKAA2 mRNA CTD PMID:30547786 paracetamol affects expression ISO Prkaa2 (Mus musculus) 6480464 Acetaminophen affects the expression of PRKAA2 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PRKAA2 mRNA CTD PMID:33387578 paraquat affects response to substance ISO Prkaa2 (Mus musculus) 6480464 PRKAA2 gene affects the susceptibility to Paraquat CTD PMID:25092649 paraquat increases expression ISO Prkaa2 (Mus musculus) 6480464 Paraquat results in increased expression of PRKAA2 protein CTD PMID:27324791 paraquat increases phosphorylation ISO Prkaa2 (Mus musculus) 6480464 Paraquat results in increased phosphorylation of PRKAA2 protein CTD PMID:25092649 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of PRKAA2 protein CTD PMID:37236338 phenobarbital decreases expression ISO Prkaa2 (Mus musculus) 6480464 Phenobarbital results in decreased expression of PRKAA2 mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO PRKAA2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of PRKAA2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKAA2 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO Prkaa2 (Mus musculus) 6480464 pirinixic acid results in increased expression of PRKAA2 mRNA CTD PMID:18301758 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of PRKAA2 mRNA CTD PMID:19236843 platycodin D multiple interactions ISO Prkaa2 (Mus musculus) 6480464 platycodin D results in increased phosphorylation of and results in increased activity of PRKAA2 protein CTD PMID:30599906 potassium chromate increases expression ISO PRKAA2 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of PRKAA2 mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile decreases expression ISO Prkaa2 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of PRKAA2 mRNA CTD PMID:28903501 progesterone increases expression EXP 6480464 Progesterone results in increased expression of PRKAA2 mRNA CTD PMID:20726854 Pseudolaric acid B multiple interactions ISO Prkaa2 (Mus musculus) 6480464 dorsomorphin inhibits the reaction [pseudolaric acid B results in increased phosphorylation of PRKAA2 protein] CTD PMID:37244295 Pseudolaric acid B increases phosphorylation ISO Prkaa2 (Mus musculus) 6480464 pseudolaric acid B results in increased phosphorylation of PRKAA2 protein CTD PMID:37244295 reactive oxygen species affects abundance ISO PRKAA2 (Homo sapiens) 6480464 PRKAA2 protein affects the abundance of Reactive Oxygen Species CTD PMID:21145922 resveratrol multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of PRKAA2 protein]] which results in decreased abundance of Triglycerides more ... CTD PMID:16873680 more ... resveratrol affects response to substance ISO Prkaa2 (Mus musculus) 6480464 PRKAA2 protein affects the susceptibility to resveratrol CTD PMID:23090186 resveratrol increases phosphorylation ISO PRKAA2 (Homo sapiens) 6480464 resveratrol results in increased phosphorylation of PRKAA2 protein CTD PMID:18482975 and PMID:20080969 resveratrol decreases expression ISO Prkaa2 (Mus musculus) 6480464 resveratrol results in decreased expression of PRKAA2 mRNA CTD PMID:22610192 resveratrol decreases activity ISO Prkaa2 (Mus musculus) 6480464 resveratrol results in decreased activity of PRKAA2 protein CTD PMID:19934007 resveratrol increases phosphorylation ISO Prkaa2 (Mus musculus) 6480464 resveratrol results in increased phosphorylation of PRKAA2 protein CTD PMID:17438283 resveratrol multiple interactions ISO Prkaa2 (Mus musculus) 6480464 PRKAA2 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]] more ... CTD PMID:17438283 more ... Salidroside multiple interactions ISO Prkaa2 (Mus musculus) 6480464 rhodioloside results in increased phosphorylation of [PRKAA1 protein binds to PRKAA2 protein] CTD PMID:37530723 Sanggenon C multiple interactions EXP 6480464 sanggenone C inhibits the reaction [Oxygen deficiency results in decreased expression of [PRKAA1 protein binds to PRKAA2 protein]] CTD PMID:28983604 SB 431542 multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos decreases methylation ISO PRKAA2 (Homo sapiens) 6480464 Asbestos and Serpentine results in decreased methylation of PRKAA2 promoter CTD PMID:29626692 silicon atom multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [Thioctic Acid co-treated with Silicon] results in increased expression of PRKAA2 mRNA CTD PMID:34252510 sodium arsenate increases expression ISO Prkaa2 (Mus musculus) 6480464 sodium arsenate results in increased expression of PRKAA2 mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO PRKAA2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of PRKAA2 mRNA CTD PMID:34032870 streptozocin multiple interactions EXP 401850547 streptozocin decreases expression and phosphorylation of Prkaa2 protein in liver RGD streptozocin multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [Streptozocin co-treated with Dietary Fats] results in decreased expression of PRKAA2 mRNA more ... CTD PMID:37337224 succimer multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRKAA2 mRNA CTD PMID:26378955 sucrose multiple interactions EXP 6480464 [Dietary Fats co-treated with Sucrose] results in decreased expression of PRKAA2 mRNA and Biological Products inhibits the reaction [[Dietary Fats co-treated with Sucrose] results in decreased expression of PRKAA2 mRNA] CTD PMID:31175915 sulindac multiple interactions EXP 6480464 [Sulindac co-treated with lipopolysaccharide and E coli O55-B5] affects the expression of PRKAA2 mRNA CTD PMID:20371263 sunitinib decreases expression EXP 329955369 sunitinib decreases expression of Ampka2 protein in rat serum and heart RGD syringin decreases phosphorylation ISO PRKAA2 (Homo sapiens) 6480464 syringin results in decreased phosphorylation of PRKAA2 protein CTD PMID:23691032 tebuconazole multiple interactions ISO Prkaa2 (Mus musculus) 6480464 [tebuconazole co-treated with Econazole] results in increased phosphorylation of PRKAA2 protein CTD PMID:30698772 telmisartan multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 Telmisartan inhibits the reaction [Dibutyl Phthalate results in increased expression of PRKAA2 protein] CTD PMID:37356649 temozolomide affects response to substance ISO PRKAA2 (Homo sapiens) 6480464 PRKAA2 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 testosterone enanthate affects expression ISO PRKAA2 (Homo sapiens) 6480464 testosterone enanthate affects the expression of PRKAA2 mRNA CTD PMID:17440010 testosterone enanthate decreases phosphorylation EXP 6480464 testosterone enanthate results in decreased phosphorylation of PRKAA2 protein CTD PMID:36015278 testosterone enanthate multiple interactions EXP 6480464 cordycepin inhibits the reaction [testosterone enanthate results in decreased phosphorylation of PRKAA2 protein] and Finasteride inhibits the reaction [testosterone enanthate results in decreased phosphorylation of PRKAA2 protein] CTD PMID:36015278 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of PRKAA2 mRNA CTD PMID:12734012 tetrachloromethane decreases expression ISO Prkaa2 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of PRKAA2 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 1 more ... CTD PMID:31150632 and PMID:35872049 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PRKAA2 mRNA CTD PMID:16239168 and PMID:31150632 tetrachloromethane affects expression ISO Prkaa2 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of PRKAA2 mRNA CTD PMID:17484886 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of PRKAA2 mRNA CTD PMID:34492290 tramadol multiple interactions EXP 6480464 [Tiletamine co-treated with Xylazine co-treated with Tramadol] results in increased expression of PRKAA2 mRNA CTD PMID:31276069 triadimefon decreases phosphorylation EXP 6480464 triadimefon results in decreased phosphorylation of PRKAA2 protein CTD PMID:36179991 trichostatin A increases expression ISO PRKAA2 (Homo sapiens) 6480464 trichostatin A results in increased expression of PRKAA2 mRNA CTD PMID:24935251 Triptolide increases expression EXP 6480464 triptolide results in increased expression of PRKAA2 mRNA CTD PMID:23639586 valproic acid increases expression ISO Prkaa2 (Mus musculus) 6480464 Valproic Acid results in increased expression of PRKAA2 mRNA CTD PMID:22045034 valproic acid increases expression ISO PRKAA2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of PRKAA2 mRNA CTD PMID:19101580 more ... valproic acid multiple interactions ISO PRKAA2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKAA2 mRNA CTD PMID:27188386 valproic acid affects expression ISO PRKAA2 (Homo sapiens) 6480464 Valproic Acid affects the expression of PRKAA2 mRNA CTD PMID:25979313 vancomycin increases expression ISO Prkaa2 (Mus musculus) 6480464 Vancomycin results in increased expression of PRKAA2 mRNA CTD PMID:18930951 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of PRKAA2 mRNA CTD PMID:23555832 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of PRKAA2 gene CTD PMID:31682807 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of PRKAA2 mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of PRKAA2 mRNA CTD PMID:23034163 xanthone multiple interactions EXP 6480464 xanthone inhibits the reaction [Isoproterenol results in decreased expression of PRKAA2 mRNA] CTD PMID:36414029 xylazine multiple interactions EXP 6480464 [Tiletamine co-treated with Xylazine co-treated with Tramadol] results in increased expression of PRKAA2 mRNA CTD PMID:31276069 zearalenone increases expression ISO Prkaa2 (Mus musculus) 6480464 Zearalenone results in increased expression of PRKAA2 mRNA CTD PMID:30717214